SOLACI Renewed Authorities During the SOLACI-CACI 2021 Congress

After a massive event attended by thousands of people, the Latin American Society of Interventional Cardiology renewed its authorities for the 2021-2023 term.

Dr. Aníbal Damonte
Dr. Aníbal Damonte (ARG)

During the closing ceremony of SOLACI-CACI 2021 Congress, Dr. Aníbal Damonte (Argentina), renowned interventional cardiologist with an extensive career, assumed the presidency of SOLACI. He succeeded Dr. José Mangione, who held the position between 2019 and 2021 and successfully conducted the difficult task of maintaining and promoting all SOLACI activities during the COVID-19 pandemic.

Dr. Damonte is a Founding Member of SOLACI, and was the Vice President of its Board. Furthermore, he served as President of the Argentine College of Interventional Cardioangiologists (CACI) and is currently the Chief of the Department of Hemodynamics and Interventional Cardiology at Rosario Cardiovascular Institute (Argentina).

Dr. Mario Araya (Chile), former Director of SOLACI Sessions and President of the Department of Hemodynamics of the Chilean Society of Cardiology (SOCHICAR) for six years, will act as Vice President. Additionally, Dr. Pedro Hidalgo (Venezuela) and Dr. Omar Santaera (Argentina) are keeping their roles of Secretary and Treasurer, respectively.

During the Congress closing ceremony, Dr. Mangione shared his satisfaction over the work done and added: We wrap-up this chapter with a successful SOLACI-CACI 2021 Congress, the final flourish. I am certain that Aníbal and the new Board will do a very good and constructive job for the Society.”

Finally, Dr. Damone thanked Dr. Mangione for the work done over the years and wished that “we all meet again face to face in the SOLACI-SOCIME 2022 Congress.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...